Switching Therapy to the Second Brand of Generic Atorvastatin: A 6-Month Retrospective Cohort, Real-World Study.

Journal: Drugs - real world outcomes
Published Date: May 11, 2025

Abstract

INTRODUCTION: High levels of low-density lipoprotein-cholesterol (LDL) is a major risk factor for cardiovascular diseases. While treatment with atorvastatin is beneficial, the original atorvastatin may be cost prohibitive to some patients. Currently, a second brand of generic atorvastatin is available on the market. This study aimed to evaluate the effectiveness of the second generic brand of atorvastatin.

Authors

  • Panisa Manasirisuk
    Department of Pharmacy Service, Faculty of Medicine, Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand.
  • Somsak Tiamkao
    Division of Neurology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Chaiyasith Wongvipaporn
    Division of Cardiology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Nanthaphan Chainirun
    Department of Pharmacy Service, Faculty of Medicine, Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand.
  • Kittisak Sawanyawisuth
    Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals